Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients

doi:10.3748/wjg.v16.i48.6155

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 48

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4468)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

449

HTML

3714

Figures (1-1)

169

Tables (1-5)

136

Sum=4468

Dec 28, 2010 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (54)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Dec 28, 2010; 16(48): 6155-6162
Published online Dec 28, 2010. doi: 10.3748/wjg.v16.i48.6155

Open in New Tab Full Size Figure Download Figure

Figure 1 Survival rates of patients after cytokine-induced killer cells immunotherapy plus chemotherapy and chemotherapy alone. CIK: Cytokine-induced killer.

Citation: Jiang JT, Shen YP, Wu CP, Zhu YB, Wei WX, Chen LJ, Zheng X, Sun J, Lu BF, Zhang XG. Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients. World J Gastroenterol 2010; 16(48): 6155-6162
URL: https://www.wjgnet.com/1007-9327/full/v16/i48/6155.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i48.6155